Enoxaparin is noninferior to unfractionated heparin in patients with non-ST elevation acute coronary syndrome treated with the use of early invasive strategy.: Results of SYNERGY Trial

被引：0
|
作者：
Gratsianskii, NA
机构：
来源：
KARDIOLOGIYA | 2004年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 79
页数：3
相关论文
共 50 条
  • [1] Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy - Primary results of the SYNERGY randomized trial
    Ferguson, JJ
    Califf, RM
    Antman, EM
    Cohen, M
    Grines, CL
    Goodman, S
    Kereiakes, DJ
    Mahaffey, KW
    Langer, A
    Nessel, CC
    Armstrong, PW
    Avezum, A
    Aylward, P
    Becker, RC
    Biasucci, L
    Borzak, S
    Col, J
    Frey, MJ
    Fry, E
    Gulba, DC
    Guneri, S
    Gurfinkel, E
    Harrington, R
    Hochman, JS
    Kleiman, NS
    Leon, MB
    Lopez-Sendon, JL
    Pepine, CJ
    Ruzyllo, W
    Steinhubl, SR
    Teirstein, PS
    Toro-Figueroa, L
    White, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (01): : 45 - 54
  • [2] OPTIMIZATION OF INVASIVE TREATMENT STRATEGY IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME
    Prilutskaya, Yu A.
    Dvoretsky, L., I
    KARDIOLOGIYA, 2018, 58 (01) : 5 - 10
  • [3] Merits of Invasive Strategy in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome
    Jneid, Hani
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [4] Enoxaparin failed to show superiority to unfractionated heparin in patients with non ST-elevation acute coronary syndrome in a phase of A to Z trial
    Gratsiansky, NA
    KARDIOLOGIYA, 2003, 43 (06) : 70 - 71
  • [5] Enoxaparin is consistently more effective than unfractionated heparin across the spectrum of risk in non-ST elevation acute coronary syndrome patients: Insights from the INTERACT trial
    Yan, AT
    Yan, RT
    Tan, M
    Armstrong, PW
    Granger, CB
    Dabbous, O
    Fox, KAA
    Eagle, KA
    Huynh, T
    Fitchett, DH
    Langer, A
    Goodman, SG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 230A - 230A
  • [6] Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin
    Gurfinkel, E
    Duronto, E
    Colorio, C
    Bozovich, G
    Cohen, M
    Mautner, B
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (03) : 227 - 232
  • [7] Thrombotic Reactant Markers in Non-ST Segment Elevation Acute Coronary Syndromes Treated with Either Enoxaparin (Low Molecular Weight Heparin) or Unfractionated Heparin
    Enrique Gurfinkel
    Ernesto Duronto
    Cecilia Colorio
    Gerardo Bozovich
    Marc Cohen
    Branco Mautner
    Journal of Thrombosis and Thrombolysis, 1999, 8 : 227 - 232
  • [8] THE STRATEGY OF MANAGEMENT PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME
    Prilutskaya, Y. A.
    Dvoretski, L., I
    KARDIOLOGIYA, 2019, 59 (09) : 40 - 51
  • [9] Efficacy and safety of percutaneous coronary intervention in acute coronary syndrome patients randomized to enoxaparin or unfractionated heparin: Results of SYNERGY
    White, HD
    Kleiman, NS
    Chew, D
    Petersen, JL
    Berdan, LG
    Traylor, L
    Mahaffey, KW
    Cohen, M
    Santos, R
    Harrington, RA
    Califf, RM
    Ferguson, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 61A - 61A
  • [10] Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes
    Conti, Elena
    Musumeci, Maria B.
    Desideri, Jasmine P.
    Ventura, Martina
    Fusco, Danilo
    Zezza, Luigi
    De Giusti, Marco
    Berni, Andrea
    Francia, Pietro
    Volpe, Massimo
    Autore, Camillo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (10) : 736 - 743
12345